By injecting the amino acid glutamine that’s been tagged with a tracer compound into patients with brain cancer, scientists have devised a technique that might enable doctors to spot growth of such tumors with high accuracy.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.